Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

View the 50 largest pharmaceutical companies in the world listings here

Servier

Servier

Rank: 35

Paris, France
servier.com

2020 Revenues ($USD) : $5,344,320,000
2020 Revenues (foreign currencies) : €4,688,000,000
2020 R&D spend : $915,420,000
2020 Number of Employees : 22,500
Fiscal Year End : 9/30/2020
Key People : Olivier Laureau, President

Governed by a foundation, Servier is an independent group that invests more than a fifth of its brand-name revenue in R&D annually. Strong in the cardiology space, it aims to become a recognized and innovative player in oncology. The company is constructing its new Servier Research and Development Institute within the Paris-Saclay scientific hub in France, with completion slated for 2022. –CN

Servier

A Servier R&D facility

Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50